Search research articles
Contact Us
Filters
Showing results (421-430 of 504) with videos related to
Page
of 51
Sort By:
Annals of the New York Academy of Sciences
|
May 31, 1993
Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity
T K Sawyer, A M Castrucci, D J Staples, et al.
Life Sciences
|
June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
V J Hruby, R S Agnes, P Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Peptides
|
January 1, 1994
The actions of melanin-concentrating hormone (MCH) on passive avoidance in rats: a preliminary study
R B McBride, B E Beckwith, R R Swenson, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Endocrinology
|
August 1, 1996
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists
B A Van Tine, B Y Azizeh, D Trivedi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 15, 1996
Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones
S J Li, K Varga, P Archer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1990
A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity
R J Knapp, L K Vaughn, S N Fang, et al.
Life Sciences
|
January 1, 1983
Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities
H I Mosberg, R Hurst, V J Hruby, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1994
Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity
L Fang, R J Knapp, R Horvath, et al.
Page
of 51
Search research articles
Search
Showing results (421-430 of 504) with videos related to
Sort By:
Page
of 51
Annals of the New York Academy of Sciences
|
May 31, 1993
Structure-activity relationships of [Nle4, D-Phe7]alpha-MSH. Discovery of a tripeptidyl agonist exhibiting sustained bioactivity
T K Sawyer, A M Castrucci, D J Staples, et al.
Life Sciences
|
June 13, 2003
Design of novel peptide ligands which have opioid agonist activity and CCK antagonist activity for the treatment of pain
V J Hruby, R S Agnes, P Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1980
4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity
T K Sawyer, P J Sanfilippo, V J Hruby, et al.
Peptides
|
January 1, 1994
The actions of melanin-concentrating hormone (MCH) on passive avoidance in rats: a preliminary study
R B McBride, B E Beckwith, R R Swenson, et al.
Life Sciences
|
May 11, 1987
Topical application of a melanotropic peptide induces systemic follicular melanogenesis
M E Hadley, S H Wood, A M Lemus-Wilson, et al.
Endocrinology
|
August 1, 1996
Low level cyclic adenosine 3',5'-monophosphate accumulation analysis of [des-His1, des- Phe6, Glu9] glucagon-NH2 identifies glucagon antagonists from weak partial agonists/antagonists
B A Van Tine, B Y Azizeh, D Trivedi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 15, 1996
Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones
S J Li, K Varga, P Archer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1990
A new, highly selective CCK-B receptor radioligand ([3H][N-methyl-Nle28,31]CCK26-33): evidence for CCK-B receptor heterogeneity
R J Knapp, L K Vaughn, S N Fang, et al.
Life Sciences
|
January 1, 1983
Cyclic penicillamine containing enkephalin analogs display profound delta receptor selectivities
H I Mosberg, R Hurst, V J Hruby, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 1, 1994
Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity
L Fang, R J Knapp, R Horvath, et al.
Page
of 51